IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $207,000 | -42.7% | 5,596 | -42.5% | 0.01% | -39.1% |
| Q1 2022 | $361,000 | +28.5% | 9,739 | +5.4% | 0.02% | +35.3% |
| Q4 2021 | $281,000 | -35.8% | 9,239 | -29.3% | 0.02% | -41.4% |
| Q3 2021 | $438,000 | -3.7% | 13,060 | +14.6% | 0.03% | -6.5% |
| Q2 2021 | $455,000 | -18.0% | 11,399 | -7.7% | 0.03% | -24.4% |
| Q1 2021 | $555,000 | -20.5% | 12,348 | 0.0% | 0.04% | -24.1% |
| Q4 2020 | $698,000 | +197.0% | 12,348 | +209.8% | 0.05% | +145.5% |
| Q2 2020 | $235,000 | -56.8% | 3,986 | -65.4% | 0.02% | -61.4% |
| Q1 2020 | $544,000 | +156.6% | 11,516 | +228.2% | 0.06% | +216.7% |
| Q4 2019 | $212,000 | -8.2% | 3,509 | -9.1% | 0.02% | -10.0% |
| Q3 2019 | $231,000 | -6.9% | 3,861 | 0.0% | 0.02% | -4.8% |
| Q2 2019 | $248,000 | +2.5% | 3,861 | +29.4% | 0.02% | 0.0% |
| Q1 2019 | $242,000 | – | 2,983 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |